Navigation Links
23andMe Announces Breast Cancer Initiative
Date:10/2/2008

Personal Genetics Leader to Focus on Building DNA-based Community For Women Impacted by Breast Cancer

CARLSBAD, Calif., Oct. 2 /PRNewswire/ -- 23andMe, Inc., the industry leader in personal genetics, today announced that it is embarking on a world-wide effort to assemble the largest cohort of women whose lives have been impacted by breast cancer and to build an infrastructure, based on genetics, that will accelerate consumer-based research of the disease.

In honor of the 23rd anniversary of October as National Breast Cancer Awareness Month, co-founders Linda Avey and Anne Wojcicki told science and business leaders at Fortune's Most Powerful Women Conference that the company will seek to reach out to, and build a community around, women who have encountered breast cancer, thereby increasing the scientific understanding of the inherited aspects of a disease that affects 200,000 newly diagnosed individuals per year.

In recent years, the scientific community has effectively utilized genetic testing to direct and dramatically improve breast cancer treatment. "Great strides have been made in targeting treatment for breast cancer," said Linda Avey. "We'd like to build on this progress, and we believe that by creating a web-based forum that enables women to share their experiences, the entire community could benefit and more personalized treatments may ultimately be an outcome."

Women who sign up for 23andMe's genetic testing service can opt-in to take surveys that help drive genome-wide association studies. Genetic profiles combined with medical and family history contribute greatly to research efforts and help researchers understand causes around disease and treatment. The company will be creating a specific breast cancer network within 23andWe, the research division of 23andMe. There, women whose lives have been touched by breast cancer can come together, build a community, share knowledge and offer advice.

"Women who have been r
'/>"/>

SOURCE 23andMe
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire/ ...: Everyone,s Problem and Heritage" , Coin..., 2-3 June 2010 the,Gabonese Republic is hosting a...n the issue of safeguarding biological resources i...nment and state leaders, ministers,scientific exp...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 T...eaders in technology development and product integ...nnounced the December 11th deadline for technology...n its 14th year, TechConnect World, in association...STI), and the Clean Technology and Sustainable Ind...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pt...vel oral JAK2 inhibitor, SB1518, at The American S...ition in New Orleans. ,, Data will be presented...alation trial of SB1518 detailing its safety, tole...D) profile in dose levels ranging from 100 to 600 ...
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ ..."Company") (NYSE: SCR ), a leading pharmaceutica...turing, and marketing of branded,generic and propr...hat 105 of,its drugs have been included in China,s...was issued by China,s Ministry of Human Resources ...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...LLESLEY HILLS, Mass., March 5 Joseph F. Finn, Jr.... ActivBiotics, confirmed,today that the sale of Ac...,through a sealed bid at 12:00 PM on March 14, 200...s parties about different aspects of the,technolog...es, in addition,to comprehensive due diligence, I ...
...ropean phase II study of 20 patients reported in A...utics, Inc.,(CTI) (Nasdaq: CTIC ; MTA) today anno...s, of results of a limited phase II study of CHOP ...istine, and prednisone) followed by,administration...atients (60,years of age or older) with previously...
...EMONT, Calif., March 4 Vermillion, Inc.,(Nasdaq: ...ighlighted recent,accomplishments across its diagn...business milestones it plans to achieve over the c... results for the fourth quarter and year,ended Dec...icant clinical and commercial,advancements in our ...
Other Biology Technology:CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 2CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 3CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 4Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 2Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 3Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 4Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 5Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 6Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 7Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 8Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 9
(Date:12/1/2009)...ology has been awarded a U.S. Air Force Center of ...vesting and adaptive materials, and to develop too... modern warfighter. , The $10.5 million Center,...anostructures and Improved Cognition (BIONIC) cent...andhage, professors in Georgia Tech,s School of Ma...
(Date:12/1/2009)...rsity-led international research team has develope...t generation of solar cells. , Scientists at Mon...rom the universities of Wollongong and Ulm in Germ...ls with a three-fold increase in energy conversion...em dye-sensitised solar cells. , Lead researche...
(Date:11/30/2009)... needed to monitor the commitments that will be ma...eir deforestation rates, according to research at ...gencies and research groups have failed to make fu... Earth,s surface collected each week to monitor tr... Alan Grainger in the Proceedings of the National...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4Innovation puts next-generation solar cells on the horizon 2World forest observatory needed to monitor vital role of forests in climate deal 2Study of DuraPrep versus chlorhexidine 59252 1Study of DuraPrep versus chlorhexidine 59252 2New approach for growing bone comes from Duke preclinical research 14418 1New approach for growing bone comes from Duke preclinical research 14418 2Loyal alligators display the mating habits of birds 10313 1Loyal alligators display the mating habits of birds 10313 2
... at Washington University in St. Louis, has discov...n-off –in this case, the turning off of thousands ...udying the phenomenon of nucleolar dominance, in w...id is silenced, Craig Pikaard, Ph.D., Washington U...ces and colleagues have identified the protein HDA...
...llogg Eye Center have gained new insight into the ...mits itself to a specific role. They have observed... has been designated to play a particular role, bu...covery provides a new vantage point for understand...raises the possibility of re-directing the product...
...sub-Saharan Africa, according to the World Health ...inst the virus have achieved limited success. But ...tted infection found widely in that region of Afri...could reduce transmission of HIV as much as 10-fol...s from the University of North Carolina at Chapel ...
Other Biology News:Researchers find protein that silences genes 2Researchers find protein that silences genes 3Researchers find protein that silences genes 4Study provides first look at the 'birth' of a retina cell 2Study provides first look at the 'birth' of a retina cell 3Vaccine shown effective against chancroid 2Vaccine shown effective against chancroid 3
...cifically for pharmaceutical powder packaging, pur...ision-joined to create ultra-smooth surfaces that ...us corners simplify cleaning. Unique double-wall p...external bracing. A supplemental CLeanZone Recircu...
...ive reagent for the detection of inorganic phospha... E. coli phosphate-binding protein labeled with th...in its environment.How it worksBinding of inorgani... (Kd ~ 0.1 M), resulting in a large increase in fl...
Distillation Hood from Terra Universal, Inc.
...logical safety labs (BSL) and pharmaceutical appli...3) and easy sterilization. Panels are precision-jo... to wipe down and disinfect. One-inch radius corne...ign creates strong, rigid surface without external...
Biology Products: